EKF Diagnostics (LON:EKF) Sets New 52-Week Low – Time to Sell?

EKF Diagnostics Holdings plc (LON:EKFGet Free Report) shares hit a new 52-week low during trading on Wednesday . The stock traded as low as GBX 23 ($0.29) and last traded at GBX 23 ($0.29), with a volume of 322279 shares traded. The stock had previously closed at GBX 24 ($0.30).

EKF Diagnostics Price Performance

The company has a quick ratio of 1.77, a current ratio of 4.60 and a debt-to-equity ratio of 0.34. The company has a market capitalization of £102.23 million, a P/E ratio of 21.40 and a beta of 0.57. The company’s fifty day moving average price is GBX 25.89 and its 200 day moving average price is GBX 27.02.

About EKF Diagnostics

(Get Free Report)

EKF is an AIM-listed global diagnostics business focussed on:

● Point-of-Care analysers in the key areas of Hematology and Diabetes

● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.

Recommended Stories

Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.